Omeprazol Rompharm (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Rompharm, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders in adults and children.

GNH USA supplies Omeprazol Rompharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related conditions: - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and promotes healing of erosive esophagitis. - Peptic ulcer disease (PUD) – gastric and ​  ulcer: supports ulcer healing and prevents recurrence. - Zollinger‑Ellison syndrome (ZES): controls excessive gastric acid production. - Helicobacter pylori eradication regimens: used as part of ​  combination therapy to improve eradication rates. - NSAID‑induced ulcer prophylaxis: reduces risk of ulcer development in at‑risk patients.

Omeprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache - Diarrhea - Nausea - Abdominal pain - Flatulence - Constipation

Serious or Rare Side Effects: - Clostridioides difficile infection - Acute interstitial nephritis - Severe hypersensitivity reactions (e.g., Stevens‑Johnson syndrome) - Low magnesium levels (hypomagnesemia) - Fracture risk with long‑term use - Vitamin B12 deficiency with prolonged therapy.

When prescribing OmOmeprazol  

- Assess   t   t   t  ewline   ewline   ewline   ewline   ewline   ewline -   -   -   ewline   -  ewline  ewline  ewline  ewline  ewline -  - ",